See every side of every news story
Published loading...Updated

MIG Capital Leads CHF 7.75 Million Seed Financing for ASTRA Therapeutics

Summary by Benzinga
MIG Capital, through its MIG Fonds, is investing 3 million Swiss Francs (CHF) in the Swiss start-up which designs precision drugs against eukaryotic pathogens. Digitalis Ventures co-leads the round with additional investment from Borealis Ventures, Kickfund and Venture Kick. Eukaryotic pathogens cause illness and death in animals, humans, and crops. MUNICH, Germany, and VILLIGEN, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) -- MIG Capital AG, one…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

startuprad.io broke the news in on Wednesday, July 23, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.